American Psychiatric Association, 1980
APA Task Force on Laboratory Tests in Psychiatry, 1987, The dexamethasone suppression test: an overview of its current status in psychiatry, Am J Psychiatry, 144, 1253, 10.1176/ajp.144.10.1253
Arana, 1984, Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone, Am J Psychiatry, 141, 1619, 10.1176/ajp.141.12.1619
Baumgartner, 1986, Serial dexamethasone suppression tests in psychiatric illness: part III. The influence of intervening variables, Psychiatry Res, 18, 45, 10.1016/0165-1781(86)90059-4
Berger, 1984, The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry, Br J Psychiatry, 145, 372, 10.1192/bjp.145.4.372
Berger, 1985, The effect of weight loss and inappropriate plasma dexamethasone levels on the DST, Psychiatry Res, 15, 351, 10.1016/0165-1781(85)90072-1
Carr, 1986, The effect of serum dexamethasone concentrations in the dexamethasone suppression test, Biol Psychiatry, 21, 735, 10.1016/0006-3223(86)90238-6
Carroll, 1980, Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression, J Clin Endocrinol Metab, 51, 433, 10.1210/jcem-51-3-433
Carroll, 1981, A specific laboratory test for the diagnosis of melancholia, 38, 15
Carson, 1987, Effect of treatment on plasma cortisol and dexamethasone, Biol Psychiatry, 22, 213, 10.1016/0006-3223(87)90233-2
Gibaldi, 1975, Pharmacokinetics, Vol 1, 45
Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56
Holsboer, 1984, Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls, Biol Psychiatry, 19, 281
Holsboer, 1986, The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics, Psychiatry Res, 17, 97, 10.1016/0165-1781(86)90064-8
Holsboer, 1986, Shortened dexamethasone half-life in depressed dexamethasone nonsuppressors, Arch Gen Psychiatry, 43, 813, 10.1001/archpsyc.1986.01800080099014
Johnson, 1984, Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients, Psychiatry Res, 13, 305, 10.1016/0165-1781(84)90078-7
Johnson, 1987, The plasma dexamethasone “window” and the dexamethasone suppression test in depression, Biol Psychiatry, 22, 1033, 10.1016/0006-3223(87)90015-1
Loew, 1986, Dose-dependent pharmacokinetics of dexamethasone, Eur J Clin Pharmacol, 30, 225, 10.1007/BF00614309
Maguire, 1987, The dexamethasone suppression test: importance of dexamethasone concentrations, Biol Psychiatry, 22, 957, 10.1016/0006-3223(87)90005-9
Morris, 1986, Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders, Br J Psychiatry, 148, 66, 10.1192/bjp.148.1.66
Poland, 1987, Neuroendocrine aspects of primary endogenous depression II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response, Arch Gen Psychiatry, 44, 790, 10.1001/archpsyc.1987.01800210034005
Poland, 1988, Serum dexamethasone concentrations in endogenous depressives before, during and after treatment: preliminary observations, Biol Psychiatry, 23, 705, 10.1016/0006-3223(88)90054-6
Rubin, 1980, Cortisol dynamics and dexamethasone pharmacokinetics in primary endogenous depression: preliminary findings, 223
SPSS Inc, 1986
Tiller, 1988, The dexamethasone suppression test in a normal population, Psychoneuroendocrinology, 13, 377, 10.1016/0306-4530(88)90044-3
Tsuei, 1979, Disposition of synthetic glucocorticoids. 1. Pharmacokinetics of dexamethasone in healthy adults, J Pharmacokinet Biopharmaceut, 7, 249, 10.1007/BF01060016
Wiedemann, 1987, Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug, Biol Psychiatry, 22, 1340, 10.1016/0006-3223(87)90068-0
Young, 1986, Pituitary regulation in endogenous depression, Progr Brain Res, 65, 153, 10.1016/S0079-6123(08)60648-2